Therapies for non-alcoholic fatty liver disease: A 2022 update

被引：0
|
作者：
Katie Shen [1 ]
Achintya D Singh [1 ]
Jamak Modaresi Esfeh [2 ]
Jamile Wakim-Fleming [2 ]
机构：
[1] Department of Internal Medicine, Cleveland Clinic Foundation
[2] Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation
来源：
World Journal of Hepatology | 2022年 / 14卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R575.5 [肝代谢障碍];
学科分类号：
1002 ; 100201 ;
摘要：
The incidence of non-alcoholic fatty liver disease(NAFLD) is rapidly increasing and lifestyle interventions to treat this disease by addressing the underlying metabolic syndrome are often limited. Many pharmacological interventions are being studied to slow or even reverse NAFLD progression. This review for hepatologists aims to provide an updated understanding of the pathogenesis of NAFLD, current recommended therapies, and the most promising treatment options that are currently under development.
引用
收藏
页码：1718 / 1729
页数：12
相关论文
共 50 条
  • [41] Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
    Ibrahim, Islam A. A. E. H.
    Amen, Yhiya
    Mostafa, Islam
    Cadiz-Gurrea, Maria De La Luz
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] Potential of incretin-based therapies for non-alcoholic fatty liver disease
    Samson, Susan L.
    Bajaj, Mandeep
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (04) : 401 - 406
  • [43] NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC FATTY PANCREAS DISEASE: A NEW INTRIGUING ASSOCIATION?
    Della Corte, Claudia
    Mosca, Antonella
    Sartorelli, Maria Rita
    Comparcola, Donatella
    Liccardo, Daniela
    Alterio, Arianna
    Lucidi, Vincenzina
    Nobili, Valerio
    [J]. DIGESTIVE AND LIVER DISEASE, 2014, 46 : E101 - E101
  • [44] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [45] Advancements in Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis Treatment: From Lifestyle Interventions to Novel Therapies
    Manteghian, Mehrab
    [J]. UNIVERSITY OF TORONTO MEDICAL JOURNAL, 2024, 101 (02)
  • [46] Non-alcoholic fatty liver disease: Epidemiology, pathophysiology and an update on the therapeutic approaches
    Abdel-Rahman, Rehab F.
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2022, 12 (03) : 99 - 114
  • [47] An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease
    Yao, Mingfei
    Qv, Lingling
    Lu, Yanmeng
    Wang, Baohong
    Berglund, Bjorn
    Li, Lanjuan
    [J]. ENGINEERING, 2021, 7 (05) : 679 - 686
  • [48] Non-alcoholic fatty liver disease: Epidemiology, pathophysiology and an update on the therapeutic approaches
    Rehab F.Abdel-Rahman
    [J]. Asian Pacific Journal of Tropical Biomedicine, 2022, (03) : 99 - 114
  • [49] Liver transplantation for non-alcoholic fatty liver disease
    Germani, Giacomo
    Becchetti, Chiara
    [J]. MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (02) : 138 - 146
  • [50] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538
12345